Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Alzheimer Disease 2Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Sleep Disorders, Circadian Rhythm 1Sleep Deprivation 1REM Sleep Behavior Disorder 1Psychological Well-Being 1Pain 1Otolaryngeal Cancer 1Neoplasm Metastasis 1Lymphoma, Follicular 1Idiopathic Hypersomnia 1Depression 1Dementia 1Combat Disorders 1Cognitive Dysfunction 1Chronobiology Disorders 1Cancer Pain 1Breast Neoplasms 1Anxiety Disorders 1Agnosia 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × Electroencephalography × Clear all
NCT02429544 2016-08-01

Effects of a Group Residential Retreat on Cancer Outcomes

M.D. Anderson Cancer Center

Phase NA Withdrawn
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡